During the past decade, Chanre Rheumatology & Immunology Center & Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chanre Rheumatology & Immunology Center & Research" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chanre Rheumatology & Immunology Center & Research" are "Systemic Lupus Erythematosus" (2 trials), "Arthritis" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Fibromyalgia" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Chanre Rheumatology & Immunology Center & Research" in a lesser frequency.

Most popular intervention types in "Chanre Rheumatology & Immunology Center & Research" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "CP-690,550" (1 trials), "DRL_RI" (1 trials), "MabThera" (1 trials) and "NSAID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chanre Rheumatology & Immunology Center & Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Chanre Rheumatology & Immunology Center & Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chanre Rheumatology & Immunology Center & Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chanre Rheumatology & Immunology Center & Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".